尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Lorianne Masuoka K., 董事. Officer active across 1 company, notably Opiant Pharmaceuticals, INC.. In total, 3 filings have been published. History available since 15 June 2021. The latest transaction was disclosed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
K. Lorianne Masuoka is a Director at OPIANT PHARMACEUTICALS, INC., a biopharmaceutical company. In this role, she participates in the governance of the company and in strategic decision-making. Her experience in the biopharmaceutical sector is valuable for OPIANT PHARMACEUTICALS, INC.